DE3926206A1 - Verfahren zur herstellung von keuchhusten-schutzantigenen - Google Patents
Verfahren zur herstellung von keuchhusten-schutzantigenenInfo
- Publication number
- DE3926206A1 DE3926206A1 DE19893926206 DE3926206A DE3926206A1 DE 3926206 A1 DE3926206 A1 DE 3926206A1 DE 19893926206 DE19893926206 DE 19893926206 DE 3926206 A DE3926206 A DE 3926206A DE 3926206 A1 DE3926206 A1 DE 3926206A1
- Authority
- DE
- Germany
- Prior art keywords
- whooping cough
- itaconic acid
- corpuscular
- microbial
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000005702 Pertussis Diseases 0.000 title claims abstract description 30
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 title claims abstract description 13
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 title claims abstract description 13
- 229960005486 vaccine Drugs 0.000 title abstract description 11
- 244000005700 microbiome Species 0.000 title abstract 2
- 230000001681 protective effect Effects 0.000 claims abstract description 29
- 230000000813 microbial effect Effects 0.000 claims abstract description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 14
- 239000013049 sediment Substances 0.000 claims abstract description 14
- 238000004062 sedimentation Methods 0.000 claims abstract description 4
- 239000000427 antigen Substances 0.000 claims description 24
- 102000036639 antigens Human genes 0.000 claims description 24
- 108091007433 antigens Proteins 0.000 claims description 24
- 239000000725 suspension Substances 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 4
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 abstract description 4
- 206010025280 Lymphocytosis Diseases 0.000 abstract description 3
- 239000011780 sodium chloride Substances 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000012258 culturing Methods 0.000 abstract description 2
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 238000011534 incubation Methods 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 239000005018 casein Substances 0.000 description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 5
- 235000021240 caseins Nutrition 0.000 description 5
- 239000003245 coal Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229940032024 DPT vaccine Drugs 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 231100000563 toxic property Toxicity 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 101710194807 Protective antigen Proteins 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- -1 mercury ions Chemical class 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012475 sodium chloride buffer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- MBMQEIFVQACCCH-QBODLPLBSA-N zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8901975A NL8901975A (nl) | 1989-07-31 | 1989-07-31 | Werkwijze voor de bereiding van tegen kinkhoest-beschermende antigenen. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3926206A1 true DE3926206A1 (de) | 1991-02-14 |
Family
ID=19855129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19893926206 Withdrawn DE3926206A1 (de) | 1989-07-31 | 1989-08-08 | Verfahren zur herstellung von keuchhusten-schutzantigenen |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE3926206A1 (enExample) |
| FR (1) | FR2650184A1 (enExample) |
| HU (1) | HU53931A (enExample) |
| NL (1) | NL8901975A (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4429046A (en) * | 1982-07-26 | 1984-01-31 | American Cyanamid Company | Large scale cultivation of Bordetella pertussis cells for vaccine production |
-
1989
- 1989-07-28 FR FR8910234A patent/FR2650184A1/fr active Pending
- 1989-07-31 NL NL8901975A patent/NL8901975A/nl not_active Application Discontinuation
- 1989-08-02 HU HU393989A patent/HU53931A/hu unknown
- 1989-08-08 DE DE19893926206 patent/DE3926206A1/de not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| Chemical Abstracts,Vol. 109, 1984, Ref. 107076k * |
Also Published As
| Publication number | Publication date |
|---|---|
| HU53931A (enExample) | 1990-12-28 |
| FR2650184A1 (fr) | 1991-02-01 |
| NL8901975A (nl) | 1991-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2902136C2 (de) | Verfahren zum Herstellen von Interferon | |
| DE3001585A1 (de) | Verfahren zur herstellung von interferon typ ii und es enthaltende zubereitungen | |
| EP2103308A1 (de) | Verfahren zur Herstellung eines Gemisches von Bakteriophagen und deren Verwendung für die Therapie von Antibiotika-resistenten Staphylococcen | |
| DE3019847C2 (de) | Verfahren zur Herstellung von Humaninterferon | |
| EP0173241B1 (de) | Vakzine zur Behandlung der Harnwegsinfektionen | |
| DE2735411A1 (de) | Verfahren zur herstellung von acellulaeren vaccinen und nach diesem verfahren gewonnene vaccine | |
| DE2813353A1 (de) | Substanz ks-2-a, verfahren zu deren herstellung und diese substanz enthaltendes mittel | |
| DE2457090C2 (de) | Verfahren zur Herstellung von Impfstoffen sowie Antibronchialimpfstoff | |
| DD202623A5 (de) | Verfahren zur herstellung von sporen-polyosiden | |
| DE68914362T2 (de) | Impfstoff, geeignet zur Verhütung bzw. Kontrolle der durch Haemophilus pleuropneumoniae verursachte Schweinekrankheit und Verfahren zu dessen Herstellung. | |
| DE60015756T2 (de) | Verfahren zur gewinnung eines thermostabilen mikroalgenextraktes mit oxidationshemmender- und wundheilender aktivität | |
| DE3926206A1 (de) | Verfahren zur herstellung von keuchhusten-schutzantigenen | |
| DE2352662A1 (de) | Verfahren zur herstellung eines uebertragungsfaktors | |
| DE1492243C3 (de) | Injizierbare Impfstoffe | |
| Fildes | The Classification of Hæmoglobinophilic Bacteria, Based upon their Relation to Blood-Pigment and to the “Vitamine” Factor | |
| CH650154A5 (de) | Wasserloesliche, biologisch aktive fraktion aus dem interzellularen medium des knochenmarks, verfahren zu deren gewinnung und diese enthaltende pharmazeutische zubereitung. | |
| DE2613943C3 (de) | Herstellung von Vaeeinen auf Ribonucleinsäurebasis | |
| DE191752C (enExample) | ||
| DE69218837T2 (de) | Bakterienwachstumsförderndes Material | |
| DE1492823A1 (de) | Verfahren zum Herstellen von Milchprodukten | |
| DE2213709A1 (de) | Verfahren zur Herstellung eines Interferonerzeugers | |
| DE1941709C3 (de) | Verfahren zur enzymatischen Vermehrung von informatorischer Ribonucleinsäure | |
| Stokinger et al. | Studies on the gonococcus: II. Properties of an antigenic fraction isolated from cell-free gonococcal broth supernatants | |
| DE2265620C2 (de) | Mittel zur passiven Immunisierung gegen die toxischen Effekte von Infektionen durch Elastase bildende Bakterien und Verfahren zur Herstellung desselben | |
| CH210423A (de) | Verfahren zur Herstellung von Bakterienprodukten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OM8 | Search report available as to paragraph 43 lit. 1 sentence 1 patent law | ||
| 8139 | Disposal/non-payment of the annual fee |